Full Press Release Details
Voting Results of 2023 Annual General Meeting
At Legend Biotech Corporation s (the Company ) annual general meeting of shareholders held on September 21, 2023 (the AGM ),
the Company s shareholders:
A total of approximately
362,167,226 ordinary shares, including those underlying ADSs, representing approximately 99.34% of the ordinary shares issued and outstanding as of August 18, 2023, the record date, were present in person or by proxy at the AGM. The results of
the votes are as follows:
| For | Against | Abstain | ||||||||||||||||||||||
| Resolutions | Votes | % | Votes | % | Votes | % | ||||||||||||||||||
| Reception of Audited Financial Statements | 362,063,064 | 99.310 | % | 732 | * | % | 103,430 | 0.028 | % | |||||||||||||||
| Ratification of appointment of Ernst & Young LLP as Independent Auditor for Fiscal Year 2023 | 361,846,756 | 99.251 | % | 283,018 | 0.078 | % | 37,452 | 0.010 | % | |||||||||||||||
| Election of Directors | ||||||||||||||||||||||||
| Dr. Li Zhu (Class III) | 360,542,838 | 98.894 | % | 1,593,518 | 0.437 | % | 30,870 | 0.008 | % | |||||||||||||||
| Dr. Corazon D. Sanders (Class III) | 352,917,796 | 96.802 | % | 9,218,874 | 2.529 | % | 30,556 | 0.008 | % | |||||||||||||||
| Dr. Li Mao (Class III) | 359,725,136 | 98.669 | % | 2,410,190 | 0.661 | % | 31,900 | 0.009 | % | |||||||||||||||
| Authorization of Directors and Officers | 362,126,314 | 99.328 | % | 11,696 | 0.003 | % | 29,216 | 0.008 | % |
Dr. Fangliang Zhang, Chairman of the Board of Directors, as the person designated by the Company, was granted a discretionary proxy by JPMorgan Chase
Bank, N.A., the depositary of the ADSs, pursuant to the Deposit Agreement governing the ADSs and the Voting Instruction Card mailed by the depositary to the holders of the ADSs, to vote 11,912,282 ordinary shares underlying ADSs for which no voting
instructions were given by the holders, and he exercised the discretionary proxy to vote in favor of each of the proposals submitted for shareholder approval at the AGM.